Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: Alcohol Clin Exp Res. 2022 Sep 11;46(10):1900–1912. doi: 10.1111/acer.14932

Table 3:

Baseline sociodemographic and clinical characteristics of randomized participants, by treatment group

Demographics Overall (N=95) N (% or SD) Ondansetron (N=46) N (% or SD) Placebo (N=49) N (% or SD) P-value
Number of participants by study site (UPenn) 67 (71%) 32 (48%); 35 (52%); 0.84*
Sex (Male) 67 (70.1%) 34 (49%) 35 (51%) 0.79
Age (yr) 51.5 (11.3) 52.9 (9.8) 50.1 (12.4) 0.23
Race (White) 60 (63%) 28 (47%) 32 (53%) 0.65
Marital Status1 50 (53%) 19 (41%) 31 (63%) 0.03
Genotype (% Responsive) 73 (77%) 34 (47%) 39 (53%) 0.51
 Employment Status 0.55
  Full-time 49 (52%) 22 (48%) 27 (55%)
  Part-time 14 (15%) 6 (13%) 8 (16%)
  Not Working 32 (34%) 18 (39%) 14 (29%)
 Years of Education 15.7 (3.2) 15.6 (3.5) 15.8 (3.0) 0.76
 Annual Income Level 0.08
  <$40,000 32 (34%) 18 (40%) 14 (29%)
  $40,000 - $79,999 17 (18%) 11 (24%) 6 (12%)
  $80,000 - $119,000 16 (17%) 4 (9%) 12 (24%)
  ≥$120,000 29 (31%) 12 (27%) 17 (35%)
Clinical Measures
 AUDIT 20.2 (6.4) 21.2 (6.7) 19.3 (6.0) 0.13
 Height (inches) 68.0 (3.2) 67.5 (3.2) 68.5 (3.2) 0.09
 Weight (pounds) 183.6 (34.9) 178.6 (35.7) 188.2 (33.9) 0.46
 BMI 27.8 (4.5) 27.4 (4.8) 28.1 (4.3) 0.62
 Lifetime Major Depression 12 (13%) 5 (11%) 7 (14%) 0.62
 Lifetime Anxiety Disorder 10 (11%) 7 (15%) 3 (6%) 0.15
 BDI Score 5.2 (5.2) 5.9 (5.5) 4.7 (4.8) 0.27
 Drinks per Drinking Day2 6.4 (2.8) 6.5 (2.8) 6.4 (2.9) 0.80
 Pct. Drinking Days2 86.9 (18.5) 86.3 (20.9) 87.4 (16.2) 0.77
 Pct. Heavy Drinking Days2 74.0 (18.3) 75.8 (25.7) 87.49 (16.2) 0.52
 SIP Score2 13.4 (9.4) 14.3 (10.2) 12.5 (8.5) 0.34
*

P-value for the comparison of study site by treatment; the other p-values refer to treatment analysis ignoring site; chi-square test for categorical variables and Kruskal-Wallis test for continuous variables